+91 95742 75666 bd@isazi.biz

Our Services

Merger & Acquisition Facilitation Services

  • Project Management 
  • Due Diligence Reporting 
  • Strategic Consulting 

Audit and Compliance Services

  • Vendor Qualification 
  • GMP Third Party Audits 
  • GMP Compliance Consulting 
  • Biostudy Monitoring 

Data Analytics & Software Solutions

  • Data Analytics in operations management 
  • Customized Software Solutions 
  • Consulting services in Data Mining Requirements 

Artwork & Labeling Services

  • State of the Art In-house Studio 
  • Artwork Preparation and Change management 
  • Artwork Proofreading and Quality Check 
  • Global Labelling Management  
  • Promotional Materials 

Medico Pharmacovigilance Services

  • Medical Information management
  • Post Marketing Pharmacovigilance 
  • Clinical trial Safety Monitoring 
  • PV Support 

Regulatory Submission Services

  • NeeS Publication 
  • eCTD Publication 
  • Legacy Submission Upgradation

Quality Management Systems

  • Designing QMS for R&D 
  • Data Integrity Assessment 
  • Audit and Compliance Assessment of CDMO 
  • Audit and Compliance Assessment of CRO for sponsors 
  • Conducting Stage Gate Review QMS Document Management 
  • Specialized Remediation of GxP issues 

Regulatory Review Cycle Management

  • Drug Master Files 
  • Country Specific Administrative Sections 
  • CMC, Clinical & Non-Clinical documentation 
  • Drafting deficiency responses 
  • Expert review of submission files 
  • Technical Information Exchange for Product Launch 

Post Approval Change Management & Compliance

  • Change Control Management
  • Annual Reports 
  • Renewals 
  • Variation submissions 
  • PADER and Safety Alerts 

Regulatory Strategic Advisory Service

  • Project Feasibility Evaluation 
  • Regulatory Intelligence 
  • Developing Quality Target Product Profile 
  • Assessment of Product 
  • Development Path 
  • Remediation of Regulatory Deficiencies & Observations 
  • Market Extension Strategies 
  • Regulatory Due Diligence For Acquisition of Marketing Authorization 
  • Regulatory Gap Analysis for Market Extension
  • Interaction with Health Authorities
  • Regulatory Submission Strategy 

Medical Devices

  • Regulatory Strategy Development
  • Pre-market Submissions
  • Quality Management Systems (QMS)
  • Post-market Surveillance

Biotechnology Products

  • Product Classification and Pathway Determination
  • Investigational New Drug (IND) Applications
  • Good Manufacturing Practice (GMP) Compliance
  • Regulatory Liaison

Biosimilars

  • Comparative Analytical Studies
  • Clinical Development Planning
  • Regulatory Submissions
  • Interchangeability Assessments

Cell & Gene Therapy (CGT)

  • Regulatory Pathway Navigation
  • Clinical Trial Design and Oversight
  • Risk Assessment and Mitigation
  • Post-Approval Monitoring